The Breakthrough T1D has launched a major funding opportunity aimed at advancing therapies that can improve cardiovascular outcomes for individuals living with type 1 diabetes (T1D). With cardiovascular disease (CVD) being a leading cause of morbidity and mortality among people with T1D, this initiative focuses on accelerating clinical trials that explore innovative therapies, whether newly […]
Access Restricted: Members-Only Content. We're sorry, but this content is available exclusively to our subscribed members: